IRON - ANVISA Registration 80027310184
Access comprehensive regulatory information for IRON in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80027310184 and manufactured by BIOTECNICA INDUSTRIA E COMERCIO LTDA. The registration is held by BIOTECNICA INDUSTRIA E COMERCIO LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including QUIBASA QUÍMICA BÁSICA LTDA, BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80027310184
25351208589201172
02534069000120
Company Information
Dates and Status
May 31, 2011
VIGENTE
09/18/2025 19:00:01
IRON
Ferro Ferrozine
Vida Biotecnologia Ltda - ME
80785070012
Mar 05, 2012
IRON
FERRO-FERROZINA
BIOSYSTEMS S.A.
10300390145
Dec 17, 2018
IRON
Ferro – Ferrozina (Reagente A+B+S)
BIOSYSTEMS S.A.
80367750130
Jun 09, 2022
IRON
FERRO DIALAB
DIALAB GMBH
10300390306
Dec 17, 2018
IRON
Ferro CAB
IN VITRO DIAGNOSTICA LTDA
10303460498
Sep 21, 2020
FERRO
FAMÍLIA FERRO
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390330
Sep 08, 2025
FERRO
KIT FERRO CROMAZUROL
MEDMAX COMÉRCIO DE EQUIPAMENTOS MÉDICOS E SIMILARES LTDA ME
81313770063
May 26, 2025
FERRO
Família Ferro FE Automação Linha DT
DAILYTECH LATINO AMERICA LTDA
80657030061
Jan 06, 2025
FERRO
IRON FERENE
DAILYTECH LATINO AMERICA LTDA
80657030033
Dec 23, 2024
FERRO
FAMÍLIA FERRO CROMAZUROL MONORREAGENTE
QUIBASA QUÍMICA BÁSICA LTDA
10269360451
May 13, 2024